Alexion Pharmaceutical Inc. buy melinda
Start price
29.09.18
/
50%
€125.50
Target price
12.03.20
€130.79
Performance (%)
-43.83%
End price
12.03.20
€70.50
Summary
This prediction ended on 12.03.20 with a price of €70.50. The BUY prediction by melinda for Alexion Pharmaceutical Inc. performed very badly with a performance of -43.83%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alexion Pharmaceutical Inc. | - | - | - | - |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% | 65.292% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% | 97.467% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% | 39.755% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% | 61.093% |
According to melinda what are the pros and cons of Alexion Pharmaceutical Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Alexion Pharmaceutical Inc. diskutieren
SecteurProduits pharmaceutiques Agenda 02/10 | 16:00 Présentation
A fin 2017, le groupe dispose d'un portefeuille DE 5 produits en développement clinique.
La répartition géographique du CA est la suivante: budget unique (43,9%), Europe (29,2%), Asie-Pacifique (9,8%) et autres (17,1%).
Nombre d'employés : 2 525 personnes.
In the thread Trading Alexion Pharmaceutical Inc.
Stopped prediction by melinda for Alexion Pharmaceutical Inc.
Alexion Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€70.50
12.03.20
12.03.20
€145.00
04.11.21
04.11.21
119.55%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Alexion Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€112.84
09.03.18
09.03.18
€153.34
10.09.18
10.09.18
-6.26%
10.09.18
10.09.18
Could be worthwhile Investment >10% per year
Alexion Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€132.65
15.09.17
15.09.17
€175.89
26.12.17
26.12.17
-18.99%
26.12.17
26.12.17
Could be worthwhile Investment >10% per year